{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-002103","form_type":"8-K","ticker":"RCKT","cik":"0001281895","company_name":"ROCKET PHARMACEUTICALS, INC.","filed_at":"2025-01-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.181082+00:00","generated_at":"2026-05-27T08:02:56.833438+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Rocket Pharmaceuticals appoints Piratip Pratumsuwan to Board; Yalamanchi resigns","bullets":["Naveen Yalamanchi resigned from Board effective Jan 25, 2025; no disagreement.","Piratip Pratumsuwan appointed to Board effective Jan 27, 2025.","Pratumsuwan is Managing Director, Research Analyst at RTW Investments, specializing in gene therapy.","Received option grants: $360k (3-year monthly vest) and $155k (1-year cliff vest).","Age 33; M.A. in Biotechnology from Columbia, B.S. in Biochemistry from McGill."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-002103","json":"https://secwatch.observer/filing/0001140361-25-002103.json","markdown":"https://secwatch.observer/filing/0001140361-25-002103.md","text":"https://secwatch.observer/filing/0001140361-25-002103.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125002103/0001140361-25-002103-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125002103/ef20042399_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T08:02:56.833438+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5859658bfc","claim":"Piratip Pratumsuwan was appointed as Director at ROCKET PHARMACEUTICALS, INC..","evidence_excerpt":"On January 25, 2025, the Board, upon the recommendation of the Nominating and Corporate Governance Committee of the Board, appointed Piratip Pratumsuwan to the Board, effective January 27, 2025.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125002103/0001140361-25-002103-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"7d14e1ac8d","claim":"Naveen Yalamanchi resigned as Director at ROCKET PHARMACEUTICALS, INC..","evidence_excerpt":"On January 25, 2025, Naveen Yalamanchi resigned from the Board of Directors (the “Board”) of Rocket Pharmaceuticals, Inc. (the “Company”), effectively immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1281895/000114036125002103/0001140361-25-002103-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}